Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Takeda Pharmaceutical Operating Income 2010-2024 | TAK

Takeda Pharmaceutical annual/quarterly operating income history and growth rate from 2010 to 2024. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • Takeda Pharmaceutical operating income for the quarter ending March 31, 2024 was $-0.126B, a 118.72% decline year-over-year.
  • Takeda Pharmaceutical operating income for the twelve months ending March 31, 2024 was $1.477B, a 59.31% decline year-over-year.
  • Takeda Pharmaceutical annual operating income for 2024 was $1.477B, a 59.31% decline from 2023.
  • Takeda Pharmaceutical annual operating income for 2023 was $3.63B, a 11.5% decline from 2022.
  • Takeda Pharmaceutical annual operating income for 2022 was $4.102B, a 82.53% decline from 2021.
  
Takeda Pharmaceutical Annual Operating Income
(Millions of US $)
2024 $1,477
2023 $3,630
2022 $4,102
2021 $23,480
2020 $924
2019 $1,845
2018 $2,176
2017 $1,450
2016 $1,086
2015 $-1,176
2014 $1,393
2013 $1,482
2012 $3,366
2011 $4,423
2010 $4,518
2009 $-4,623
Takeda Pharmaceutical Quarterly Operating Income
(Millions of US $)
2024-03-31 $-126
2023-12-31 $713
2023-09-30 $-340
2023-06-30 $1,231
2023-03-31 $675
2022-12-31 $1,044
2022-09-30 $752
2022-06-30 $1,159
2022-03-31 $-72
2021-12-31 $1,025
2021-09-30 $887
2021-06-30 $2,262
2021-03-31 $20,096
2020-12-31 $1,374
2020-09-30 $454
2020-06-30 $1,556
2020-03-31 $-34
2019-12-31 $492
2019-09-30 $376
2019-06-30 $90
2018-12-31 $1,001
2018-06-30 $910
2017-06-30 $1,755
2016-06-30 $1,422
2015-06-30 $406
2015-03-31 $3,673
2014-12-31 $-10,919
2014-09-30 $4,076
2014-06-30 $612
2014-03-31 $3,982
2013-12-31 $4,528
2013-09-30 $4,222
2013-06-30 $509
2013-03-31 $3,722
2012-12-31 $4,959
2012-09-30 $4,936
2012-06-30 $892
2012-03-31 $4,816
2011-12-31 $5,484
2011-09-30 $4,454
2011-03-31 $4,113
2010-03-31 $3,728
2009-09-30 $2
2009-03-31 $3,594
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $40.858B $28.196B
Takeda Pharmaceutical Company Limited operates as a research-based pharmaceutical company, engaged in manufacturing, marketing, and importing/exporting pharmaceutical drugs. Takeda's core business comprise of ethical drugs and its portfolio includes lansoprazole for the treatment of peptic ulcers, leuprolide acetate for the treatment of prostate cancer and endometriosis, pioglitazone hydrocholoride for the treatment of diabetes, and candesartan cilexetil for the treatment of hypertension. The Company promotes enhancing R&D pipeline, while concentrating its management resources to the four core therapeutic areas: lifestyle-related diseases, oncology and urological diseases, central nervous system disease and gastroenterological diseases. It operates in two segments- Ethical drug business and Consumer healthcare business. Consumer healthcare business provides Alinamin (vitamin B1 derivative preparations, etc.), Benza (cold remedies). Takeda Pharmaceutical Company Limited is headquartered in Osaka, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.518B 32.74
Chugai Pharmaceutical (CHGCY) Japan $59.516B 26.60
Merck (MKGAF) Germany $21.654B 21.00
Astellas Pharma (ALPMY) Japan $17.952B 28.34
Sandoz Group AG (SDZNY) Switzerland $15.762B 0.00
United Therapeutics (UTHR) United States $14.058B 14.98
Neurocrine Biosciences (NBIX) United States $13.517B 37.00
Shionogi (SGIOY) Japan $11.482B 9.98
Catalent (CTLT) United States $10.209B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.379B 0.00
Ionis Pharmaceuticals (IONS) United States $6.894B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.754B 7.42
Revolution Medicines (RVMD) United States $6.357B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.088B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $5.525B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.428B 0.00
Corcept Therapeutics (CORT) United States $3.338B 30.25
Arrowhead Pharmaceuticals (ARWR) United States $3.191B 0.00
Dyne Therapeutics (DYN) United States $3.095B 0.00
PTC Therapeutics (PTCT) United States $2.658B 0.00
Indivior (INDV) United States $2.258B 10.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.982B 11.26
Recursion Pharmaceuticals (RXRX) United States $1.800B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.776B 17.29
NewAmsterdam Pharma (NAMS) Netherlands $1.758B 0.00
Evotec AG (EVO) Germany $1.619B 0.00
Ardelyx (ARDX) United States $1.513B 0.00
Soleno Therapeutics (SLNO) United States $1.395B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.375B 0.00
Pacira BioSciences (PCRX) United States $1.299B 12.35
BioCryst Pharmaceuticals (BCRX) United States $1.261B 0.00
Xencor (XNCR) United States $1.184B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.148B 0.00
Enliven Therapeutics (ELVN) United States $1.103B 0.00
4D Molecular Therapeutics (FDMT) United States $1.082B 0.00
Collegium Pharmaceutical (COLL) United States $1.061B 6.35
Ocular Therapeutix (OCUL) United States $1.047B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.970B 15.12
Cassava Sciences (SAVA) United States $0.909B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.902B 0.00
Cronos Group (CRON) Canada $0.895B 0.00
USANA Health Sciences (USNA) United States $0.867B 14.18
Relay Therapeutics (RLAY) United States $0.836B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.802B 0.00
ARS Pharmaceuticals (SPRY) United States $0.780B 0.00
Harrow (HROW) United States $0.743B 0.00
Sage Therapeutics (SAGE) United States $0.643B 0.00
Exscientia (EXAI) United Kingdom $0.631B 0.00
Silence Therapeutics (SLN) United Kingdom $0.569B 0.00
ProKidney (PROK) United States $0.555B 0.00
Savara (SVRA) United States $0.527B 0.00
Siga Technologies (SIGA) United States $0.523B 6.69
Heron Therapeutics (HRTX) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.508B 0.00
Lexeo Therapeutics (LXEO) United States $0.490B 0.00
Larimar Therapeutics (LRMR) United States $0.469B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.469B 0.00
Bioventus (BVS) United States $0.453B 17.33
Altimmune (ALT) United States $0.453B 0.00
OmniAb (OABI) United States $0.443B 0.00
Esperion Therapeutics (ESPR) United States $0.438B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.405B 0.00
Verve Therapeutics (VERV) United States $0.400B 0.00
Lyell Immunopharma (LYEL) United States $0.352B 0.00
Organogenesis (ORGO) United States $0.350B 66.00
Tourmaline Bio (TRML) United States $0.339B 0.00
Xeris Biopharma Holdings (XERS) United States $0.335B 0.00
Korro Bio (KRRO) United States $0.310B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.306B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.89
Enanta Pharmaceuticals (ENTA) United States $0.268B 0.00
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Nanobiotix S.A (NBTX) France $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.244B 0.00
Aquestive Therapeutics (AQST) United States $0.236B 0.00
ESSA Pharma (EPIX) Canada $0.230B 0.00
Eliem Therapeutics (ELYM) United States $0.224B 0.00
Profound Medical (PROF) Canada $0.217B 0.00
Century Therapeutics (IPSC) United States $0.214B 0.00
Elite Pharmaceuticals (ELTP) United States $0.214B 20.00
Fractyl Health (GUTS) United States $0.212B 0.00
Nektar Therapeutics (NKTR) United States $0.210B 0.00
Akebia Therapeutics (AKBA) United States $0.207B 0.00
Avita Medical (RCEL) United States $0.205B 0.00
Prelude Therapeutics (PRLD) United States $0.203B 0.00
Aldeyra Therapeutics (ALDX) United States $0.202B 0.00
Zevra Therapeutics (ZVRA) United States $0.201B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Pyxis Oncology (PYXS) United States $0.189B 0.00
Acrivon Therapeutics (ACRV) United States $0.178B 0.00
Incannex Healthcare (IXHL) Australia $0.169B 0.00
Adherex Technologies (FENC) United States $0.168B 205.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Context Therapeutics (CNTX) United States $0.151B 0.00
CytoDyn (CYDY) United States $0.148B 0.00
Metagenomi (MGX) United States $0.141B 0.00
MediWound (MDWD) Israel $0.138B 0.00
Cardiol Therapeutics (CRDL) Canada $0.138B 0.00
Galectin Therapeutics (GALT) United States $0.137B 0.00
Regulus Therapeutics (RGLS) United States $0.133B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.131B 8.77
Telomir Pharmaceuticals (TELO) United States $0.127B 0.00
Assertio Holdings (ASRT) United States $0.125B 5.70
OptiNose (OPTN) United States $0.122B 0.00
Karyopharm Therapeutics (KPTI) United States $0.121B 0.00
VAXART, INC (VXRT) United States $0.118B 0.00
Citius Pharmaceuticals (CTXR) United States $0.115B 0.00
Journey Medical (DERM) United States $0.103B 0.00
FibroGen (FGEN) United States $0.102B 0.00
Relmada Therapeutics (RLMD) United States $0.090B 0.00
AlloVir (ALVR) United States $0.090B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
PMV Pharmaceuticals (PMVP) United States $0.085B 0.00
ProPhase Labs (PRPH) United States $0.081B 0.00
Aclaris Therapeutics (ACRS) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.077B 1.08
Conduit Pharmaceuticals (CDT) United States $0.075B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.068B 0.00
CASI Pharmaceuticals (CASI) China $0.066B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
Carisma Therapeutics (CARM) United States $0.053B 0.00
Mural Oncology (MURA) Ireland $0.052B 0.00
Tempest Therapeutics (TPST) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Inotiv (NOTV) United States $0.045B 0.00
Protara Therapeutics (TARA) United States $0.045B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.043B 0.00
DURECT (DRRX) United States $0.042B 0.00
Lipocine (LPCN) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.031B 0.00
VYNE Therapeutics (VYNE) United States $0.029B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
BioVie (BIVI) United States $0.027B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Viracta Therapeutics (VIRX) United States $0.023B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Minerva Neurosciences (NERV) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
TherapeuticsMD (TXMD) United States $0.020B 0.00
Iterum Therapeutics (ITRM) Ireland $0.020B 0.00
JanOne (JAN) United States $0.020B 0.00
MEI Pharma (MEIP) United States $0.020B 0.75
Indaptus Therapeutics (INDP) United States $0.019B 0.00
SHINECO (SISI) China $0.019B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Unicycive Therapeutics (UNCY) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Alaunos Therapeutics (TCRT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Traws Pharma (TRAW) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.83
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 31.75